ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,575.90
-1.39%
S&P ASX All Technology
2,970.40
-1.25%
Brent Oil
88.165
0.00%
US Dollar vs AUD
1.53139
0.00%
Bitcoin
63,756.69
0.54%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. BioLineRx Ltd (BLRX)

  7. BioLineRx Ltd (BLRX) News

BLRX BioLineRx Ltd

0.6599
0.0846 (14.71%)
27 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
BioLineRx Ltd BLRX NASDAQ Depository Receipt
  Price Change Price Change % Share Price Last Trade
Upgrade Icon
0.0846 14.71% 0.6599 14:00:09
Open Price Low Price High Price Close Price Previous Close
0.5614 0.5528 0.6216 0.6116 0.5753
more quote information »

Recent News

Date Time Source Heading
17/4/202421:00PRNUSBioLineRx Announces Poster Presentation on Apheresis Center..
04/3/202423:47EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
28/2/202423:08EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
16/2/202423:07EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
08/1/202416:15EDGAR2Form EFFECT - Notice of Effectiveness
30/12/202308:20EDGAR2Form S-8 - Securities to be offered to employees in employee..
30/12/202308:15EDGAR2Form F-3 - Registration statement by foreign private issuers
21/12/202323:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/12/202323:07EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
20/11/202323:03EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
20/11/202322:25IHMARKETNEWSMonday’s Wall Street Highlights: GM, Microsoft, Citigroup,..
01/11/202322:43PRNCABioLineRx a conclu un accord de licence exclusive pour le..
01/11/202300:00PRNCABioLineRx entered Exclusive License Agreement to..
27/10/202305:18EDGAR2Form SC 13D - General statement of acquisition of beneficial..
19/10/202308:07APSNew Collaboration Could Revolutionize Treatment of Chronic..
12/10/202322:14EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
28/9/202321:11EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/9/202321:07EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/9/202321:00PRNUSBioLineRx Announces FDA Approval of APHEXDA™ (motixafortide)..
30/8/202321:16IHMARKETNEWSWednesday’s Wall Street Highlights: Ambarella, Alphabet,..
30/8/202321:15EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
30/8/202320:45EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
09/8/202307:25EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
17/7/202321:10EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..

Your Recent History

NASDAQ
BLRX
BioLineRx
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved